Security key
019770106
Allogene Therapeutics, Inc. - Common Stock, $0.001 par value per share (ALLO)
CUSIP: 019770106
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 183,617,614
- Total 13F value
- $207,883,293
- Share change
- -13,320,916
- Put/Call ratio
- 66%
- SEC-reported price per share
- $1.13
- Number of holders
- 153
- Value change
- -$15,409,926
- Number of buys
- 68
- Number of sells
- 70
- Shares outstanding
- 347,232,964
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
153
Top holders
10
ALLO full security history
Ownership snapshot
Full 13F holder table
Allogene Therapeutics, Inc. SEC filings
Allogene Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ALLO - Allogene Therapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
TPG GP A, LLC
Comparable rows
15/15
Latest evidence
31 Mar 2025
13F
13D/G
3/4/5
Lead comparable stake: 5.3%
13D/G row: BlackRock, Inc.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 5.3%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
5.3%
FMR LLC
4.9%
PFIZER INC
6.3%
TPG GP A, LLC
5.4%
Capital World Investors
3.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
5.3%
from 13D/G
|
$26,182,043
17,932,906 shares
|
— | 31 Mar 2025 |
| FMR LLC |
13D/G
13F
Company
|
4.9%
|
$15,747,811
10,225,851 shares
|
-$20,861,062 | 28 Feb 2025 |
| PFIZER INC |
13F
Company
|
6.3%
|
$32,166,778
22,032,040 shares
|
— | 31 Mar 2025 |
| TPG GP A, LLC |
3/4/5
13F
10%+ Owner · Company
|
5.4%
from 13F
|
$59,413,042
18,716,306 shares
|
— | 12 Jan 2022 |
| Capital World Investors |
13F
Company
|
3.5%
|
$17,907,382
12,265,330 shares
|
— | 31 Mar 2025 |
| Lynx1 Capital Management LP |
13F
Company
|
3.2%
|
$16,143,233
11,057,009 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
153
Shares
183,617,614
Rows available
153
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
167
Q2 2025 holders
153
Holder diff
-14
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|